GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Haemonetics Corp (NYSE:HAE) » Definitions » Cyclically Adjusted PB Ratio

Haemonetics (Haemonetics) Cyclically Adjusted PB Ratio : 5.47 (As of May. 21, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Haemonetics Cyclically Adjusted PB Ratio?

As of today (2024-05-21), Haemonetics's current share price is $95.27. Haemonetics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $17.43. Haemonetics's Cyclically Adjusted PB Ratio for today is 5.47.

The historical rank and industry rank for Haemonetics's Cyclically Adjusted PB Ratio or its related term are showing as below:

HAE' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.94   Med: 4   Max: 9.02
Current: 5.47

During the past years, Haemonetics's highest Cyclically Adjusted PB Ratio was 9.02. The lowest was 1.94. And the median was 4.00.

HAE's Cyclically Adjusted PB Ratio is ranked worse than
80.81% of 469 companies
in the Medical Devices & Instruments industry
Industry Median: 2.14 vs HAE: 5.47

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Haemonetics's adjusted book value per share data for the three months ended in Mar. 2024 was $18.902. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $17.43 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Haemonetics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Haemonetics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haemonetics Cyclically Adjusted PB Ratio Chart

Haemonetics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.48 7.09 3.79 4.84 4.90

Haemonetics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.84 4.95 5.18 4.98 4.90

Competitive Comparison of Haemonetics's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Haemonetics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Haemonetics's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Haemonetics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Haemonetics's Cyclically Adjusted PB Ratio falls into.



Haemonetics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Haemonetics's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=95.27/17.43
=5.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haemonetics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Haemonetics's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=18.902/131.7762*131.7762
=18.902

Current CPI (Mar. 2024) = 131.7762.

Haemonetics Quarterly Data

Book Value per Share CPI Adj_Book
201406 15.848 100.560 20.768
201409 15.987 100.428 20.977
201412 16.195 99.070 21.542
201503 15.988 99.621 21.149
201506 15.557 100.684 20.361
201509 15.347 100.392 20.145
201512 14.165 99.792 18.705
201603 14.167 100.470 18.581
201606 14.014 101.688 18.161
201609 14.536 101.861 18.805
201612 14.875 101.863 19.243
201703 14.154 102.862 18.133
201706 14.713 103.349 18.760
201709 15.206 104.136 19.242
201712 15.412 104.011 19.526
201803 14.375 105.290 17.991
201806 13.053 106.317 16.179
201809 13.585 106.507 16.808
201812 12.612 105.998 15.679
201903 13.090 107.251 16.083
201906 11.640 108.070 14.193
201909 11.535 108.329 14.032
201912 11.403 108.420 13.859
202003 11.667 108.902 14.118
202006 12.010 108.767 14.551
202009 13.173 109.815 15.807
202012 14.152 109.897 16.970
202103 14.383 111.754 16.960
202106 13.273 114.631 15.258
202109 13.681 115.734 15.577
202112 14.298 117.630 16.018
202203 14.659 121.301 15.925
202206 15.013 125.017 15.825
202209 14.406 125.227 15.159
202212 15.383 125.222 16.188
202303 16.214 127.348 16.778
202306 17.052 128.729 17.456
202309 17.612 129.860 17.872
202312 18.575 129.419 18.913
202403 18.902 131.776 18.902

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Haemonetics  (NYSE:HAE) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Haemonetics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Haemonetics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Haemonetics (Haemonetics) Business Description

Traded in Other Exchanges
Address
125 Summer Street, Boston, MA, USA, 02110
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
Executives
Stewart W Strong officer: President, Global Hospital C/O HAEMONETICS CORPORATION, 125 SUMMER STREET, BOSTON MA 02110
Anila Lingamneni officer: EVP, Chief Technology Officer HAEMONETICS CORPORATION, 125 SUMMER STREET, BOSTON MA 02110
Charles J Dockendorff director COVIDIEN LTD., 15 HAMPSHIRE STREET, MANSFIELD MA 02048
Diane M Bryant director 2200 MISSION COLLEGE BLVD, SANTA CLARA CA 95054
Josep Llorens officer: EVP, Global Manufacturing HAEMONETICS CORPORATION, 400 WOOD ROAD, BRAINTREE MA 02184
Michelle L Basil officer: EVP and General Counsel HAEMONETICS CORPORATION, 400 WOOD ROAD, BRAINTREE MA 02184
Farris Maryanne Maunsell officer: VP, Chief Accounting Officer C/O HAEMONETICS CORPORATION, 125 SUMMER STREET, BOSTON MA 02110
Roy Galvin officer: President, Global Plasma & BC C/O HAEMONETICS CORPORATION, 125 SUMMER STREET, BOSTON MA 02110
Laurie A. Miller officer: SVP, Human Resources C/O HAEMONETICS CORPORATION, 125 SUMMER STREET, BOSTON MA 02110
Mark W Kroll director PO BOX 23, CRYSTAL BAY MN 55323
Dan Goldstein officer: VP, Corporate Controller HAEMONETICS CORPORATION, 400 WOOD ROAD, BRAINTREE MA 02184
Christopher Simon, director, officer: President & CEO HAEMONETICS CORPORATION, 400 WOOD ROAD, BRAINTREE MA 02184
James Darecca officer: EVP, Chief Financial Officer C/O HAEMONETICS CORPORATION, 125 SUMMER STREET, BOSTON MA 02110
Burke William P. Mr. officer: EVP, Chief Financial Officer HAEMONETICS CORPORATION, 400 WOOD ROAD, BRAINTREE MA 02184
Lloyd Emerson Johnson director 16737 NEW PROVIDENCE LANE, CHARLOTTE NC 28277